LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy

BACKGROUND: Low molecular weight protein tyrosine phosphatase (LMW-PTP) is overexpressed in different cancer types and its expression is related to more aggressive disease, reduced survival rate and drug resistance. Morin is a natural polyphenol which negatively modulates, among others, the activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Capitani, Nagaja, Lori, Giulia, Paoli, Paolo, Patrussi, Laura, Troilo, Arianna, Baldari, Cosima T., Raugei, Giovanni, D’Elios, Mario Milco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429822/
https://www.ncbi.nlm.nih.gov/pubmed/30948927
http://dx.doi.org/10.1186/s12935-019-0786-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429822/
https://www.ncbi.nlm.nih.gov/pubmed/30948927
http://dx.doi.org/10.1186/s12935-019-0786-1

Ejemplares similares